Medical Advancement

Three Gulf States Reach Out to Israel for Help Battling COVID-19 Pandemic

Monday, May 11, 2020

Three states in the Arab Gulf are actively engaged in cooperation with Israel’s health system, with one having recently asked for help installing an advanced telemedicine system to confront the coronavirus pandemic, a senior official at one of the country’s leading hospitals said Sunday. Top representatives from Bahrain and the United Arab Emirates have been … Read More

Israel’s IIBR Completes Development Phase of COVID-19 Antibody

Tuesday, May 5, 2020

The Israel Institute for Biological Research (IIBR) has completed the development phase of COVID-19 antibody or passive vaccine, according to a statement by the Defense Ministry.  Defense Minister Naftali Bennett visited the Ness Ziona-based lab on Monday and was briefed by the research team, who revealed a breakthrough antibody that attacks the virus and neutralizes … Read More

Israeli Developers of Corona Vaccine to Initiate Human Clinical Trials in Summer

Monday, April 27, 2020

An Israeli company working on a COVID-19 vaccine will begin human trials this summer, a senior company official said on Wednesday. MigVax, an affiliate of the Migal Galilee Research Institute, will conduct safety and efficacy assessment in rodents starting next month. Phase 1 of clinical trials in humans will start during the summer and last … Read More

OurCrowd to Back Israeli COVID-19 Vaccine Company in $12 Million Round

Friday, April 24, 2020

Jerusalem-based equity crowdfunding company OurCrowd will lead a $12 million investment round for newly formed Covid-19 vaccine company MigVax, the company announced in a statement on Wednesday. MigVax intends to use the funds to accelerate the development of a coronavirus vaccine and bring it to the market. “We are humbled by the opportunity to invest … Read More

Tel Aviv University Professor Granted US Patent for Coronavirus Vaccine Design

Tuesday, April 21, 2020

A professor at Tel Aviv University (TAU) has been granted a patent by the United States Patent and Trademark Office (USPTO) for his innovative vaccine design for the novel coronavirus, also known as SARS-CoV-2, TAU announced on Sunday. Prof. Jonathan Gershoni of the School of Molecular Cell Biology and Biotechnology at TAU’s George S. Wise Faculty … Read More

US Patient Receives Israeli Coronavirus Treatment with 100 Percent Survival Rate

Friday, April 17, 2020

An American patient diagnosed with the coronavirus (COVID-19) has been given a treatment by Israeli-based Pluristem that, so far, has a 100 percent survival rate. The development, which occurred under the Israel’s compassionate-use program, comes days after the company released preliminary data showing that six critically ill coronavirus patients in the Jewish state who are … Read More

New Israeli COVID -19 Treatment Seemingly Successful with First Two Patients

Thursday, April 16, 2020

The first two patients who were treated with a new Israeli treatment for the novel COVID-19 after testing positive have shown significant improvement, with one of them even being removed from the intensive care unit (ICU) within days of treatment. Israeli biopharmaceutical RedHill Biopharma Ltd. administered their experimental drug, Opaganib, in Israel for the first time last … Read More

Hebrew University Gets $4.2 Million From Rothschild Foundation For Coronavirus Fight

Tuesday, April 14, 2020

The Hebrew University of Jerusalem has received a $4.2 million donation from the Edmond de Rothschild Foundation to fund coronavirus research. The money will be used to fund 60 Hebrew University research teams that are “working to find a vaccine, produce faster and cheaper testing methods, and develop targeted treatments for those afflicted by COVID-19,” … Read More

Israeli Researchers at Hebrew U Develop Faster, Cheaper COVID-19 Test

Monday, April 13, 2020

Researchers at the Hebrew University of Jerusalem announced on Sunday that they have developed a new method of testing for COVID-19 which is not only 4-10 times faster than the tests most commonly used today, but also significantly cheaper, while supplying the same level of accuracy. Moreover, most of the materials required to perform the … Read More